211 related articles for article (PubMed ID: 33347638)
1. O-glycosylated clusterin as a sensitive marker for diagnosing early stages of prostate cancer.
Kazuno S; Fujimura T; Fujime M; Miura Y; Ueno T
Prostate; 2021 Feb; 81(3):170-181. PubMed ID: 33347638
[TBL] [Abstract][Full Text] [Related]
2. Glycosylation status of serum immunoglobulin G in patients with prostate diseases.
Kazuno S; Furukawa J; Shinohara Y; Murayama K; Fujime M; Ueno T; Fujimura T
Cancer Med; 2016 Jun; 5(6):1137-46. PubMed ID: 26880719
[TBL] [Abstract][Full Text] [Related]
3. Analysis of serum glycome by lectin microarrays for prostate cancer patients - a search for aberrant glycoforms.
Bertok T; Jane E; Chrenekova N; Hroncekova S; Bertokova A; Hires M; Vikartovska A; Kubanikova P; Sokol R; Fillo J; Kasak P; Borsig L; Tkac J
Glycoconj J; 2020 Dec; 37(6):703-711. PubMed ID: 33119808
[TBL] [Abstract][Full Text] [Related]
4. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.
Tabarés G; Radcliffe CM; Barrabés S; Ramírez M; Aleixandre RN; Hoesel W; Dwek RA; Rudd PM; Peracaula R; de Llorens R
Glycobiology; 2006 Feb; 16(2):132-45. PubMed ID: 16177264
[TBL] [Abstract][Full Text] [Related]
5. An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis.
Ishikawa T; Yoneyama T; Tobisawa Y; Hatakeyama S; Kurosawa T; Nakamura K; Narita S; Mitsuzuka K; Duivenvoorden W; Pinthus JH; Hashimoto Y; Koie T; Habuchi T; Arai Y; Ohyama C
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241428
[TBL] [Abstract][Full Text] [Related]
6. Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.
Hagiwara K; Tobisawa Y; Kaya T; Kaneko T; Hatakeyama S; Mori K; Hashimoto Y; Koie T; Suda Y; Ohyama C; Yoneyama T
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134773
[No Abstract] [Full Text] [Related]
7. Lectin Affinity Chromatography for the Discovery of Novel Cancer Glycobiomarkers: A Case Study with PSA Glycoforms and Prostate Cancer.
Llop E; Peracaula R
Methods Mol Biol; 2022; 2370():301-313. PubMed ID: 34611876
[TBL] [Abstract][Full Text] [Related]
8. Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns.
Meany DL; Zhang Z; Sokoll LJ; Zhang H; Chan DW
J Proteome Res; 2009 Feb; 8(2):613-9. PubMed ID: 19035787
[TBL] [Abstract][Full Text] [Related]
9. Identification of Multisialylated LacdiNAc Structures as Highly Prostate Cancer Specific Glycan Signatures on PSA.
Haga Y; Uemura M; Baba S; Inamura K; Takeuchi K; Nonomura N; Ueda K
Anal Chem; 2019 Feb; 91(3):2247-2254. PubMed ID: 30669833
[TBL] [Abstract][Full Text] [Related]
10. Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects.
Fujimura T; Shinohara Y; Tissot B; Pang PC; Kurogochi M; Saito S; Arai Y; Sadilek M; Murayama K; Dell A; Nishimura S; Hakomori SI
Int J Cancer; 2008 Jan; 122(1):39-49. PubMed ID: 17803183
[TBL] [Abstract][Full Text] [Related]
11. An endoglycosidase-assisted LC-MS/MS-based strategy for the analysis of site-specific core-fucosylation of low-concentrated glycoproteins in human serum using prostate-specific antigen (PSA) as example.
Lang R; Leinenbach A; Karl J; Swiatek-de Lange M; Kobold U; Vogeser M
Clin Chim Acta; 2018 May; 480():1-8. PubMed ID: 29408166
[TBL] [Abstract][Full Text] [Related]
12. Study of glycosylation of prostate-specific antigen secreted by cancer tissue-originated spheroids reveals new candidates for prostate cancer detection.
Ideo H; Kondo J; Nomura T; Nonomura N; Inoue M; Amano J
Sci Rep; 2020 Feb; 10(1):2708. PubMed ID: 32066783
[TBL] [Abstract][Full Text] [Related]
13. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy.
Ohyama C; Hosono M; Nitta K; Oh-eda M; Yoshikawa K; Habuchi T; Arai Y; Fukuda M
Glycobiology; 2004 Aug; 14(8):671-9. PubMed ID: 15044396
[TBL] [Abstract][Full Text] [Related]
14. Development of glycan specific lectin based immunoassay for detection of prostate specific antigen.
Bhanushali PB; Badgujar SB; Tripathi MM; Gupta S; Murthy V; Krishnasastry MV; Puri CP
Int J Biol Macromol; 2016 May; 86():468-80. PubMed ID: 26840176
[TBL] [Abstract][Full Text] [Related]
15. Investigation on core-fucosylated prostate-specific antigen as a refined biomarker for differentiation of benign prostate hyperplasia and prostate cancer of different aggressiveness.
Lang R; Rolny V; Leinenbach A; Karl J; Swiatek-de Lange M; Kobold U; Schrader M; Krause H; Mueller M; Vogeser M
Tumour Biol; 2019 Mar; 41(3):1010428319827223. PubMed ID: 30907281
[TBL] [Abstract][Full Text] [Related]
16. Focused differential glycan analysis with the platform antibody-assisted lectin profiling for glycan-related biomarker verification.
Kuno A; Kato Y; Matsuda A; Kaneko MK; Ito H; Amano K; Chiba Y; Narimatsu H; Hirabayashi J
Mol Cell Proteomics; 2009 Jan; 8(1):99-108. PubMed ID: 18697734
[TBL] [Abstract][Full Text] [Related]
17. alpha1,2-Fucosylated and beta-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer.
Fukushima K; Satoh T; Baba S; Yamashita K
Glycobiology; 2010 Jan; 20(4):452-60. PubMed ID: 20008118
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of molecular species of prostate-specific antigen complexed with immunoglobulin M in prostate cancer and benign prostatic hyperplasia.
Goč S; Janković M
Dis Markers; 2013; 35(6):847-55. PubMed ID: 24367138
[TBL] [Abstract][Full Text] [Related]
19. Serum level of clusterin and its density in men with prostate cancer as novel biomarkers reflecting disease extension.
Miyake H; Muramaki M; Furukawa J; Kurahashi T; Fujisawa M
Urology; 2010 Feb; 75(2):454-9. PubMed ID: 19854485
[TBL] [Abstract][Full Text] [Related]
20. Levels of plasma glycan-binding auto-IgG biomarkers improve the accuracy of prostate cancer diagnosis.
Dos Santos JM; Joiakim A; Kaplan DJ; Putt DA; Perez Bakovic G; Servoss SL; Rybicki BA; Dombkowski AA; Kim H
Mol Cell Biochem; 2021 Jan; 476(1):13-22. PubMed ID: 32816187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
